Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Predictor Factors of Recurrence in Bipolar Disorder in Spain

NCT00690859 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00690859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00690859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Predictor Factors of Recurrence in Bipolar Disorder in Spain
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
June 30, 2007
Completion date
March 31, 2009
Enrollment
595 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder